1,25-Dihydroxyvitamin D ₃ Receptors in Human Leukocytes

Abstract

A 1,25-dihydroxyvitamin D3 receptor macromolecule was detected in peripheral mononuclear leukocytes from normal humans. This macromolecule was found to be present in monocytes but absent from normal resting peripheral B and T lymphocytes. However, it was present in established lines of malignant B, T, and non-B, non-T human lymphocytes, as well as in T and B lymphocytes obtained from normal humans and activated in vitro.

Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study

“…Experimental studies show that the active form of vitamin D, 1,25D 3 , has anti-proliferative and pro-differentiation effects on cells that possess vitamin D receptors, 49 including lymphocytes 50 and lymphoma cell lines. 51 There is also evidence that 1,25D 3 induces apoptosis and inhibits angiogenesis and tumour spread.…”

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity

“…26 The fact that expression of these receptors occurs in activated, but not resting, T lymphocytes 27 and B lymphocytes 28 provided evidence of a functional role for vitamin D as a modulator of the acquired (adaptive) arm of the immune system.…”

Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?

“…During the 1980s vitamin D receptors were identified on cells of the immune system (53,54) sparking interest in immunemodulating effects of vitamin D. For IBD, there is a compelling body of evidence from animal models that vitamin D has the capacity to alter immune responses (11,(55)(56)(57) . Vitamin D deficiency, for example, accelerates the development of experimental colitis in IL-10 knock-out mice, (12) whereas treatment with dietary vitamin D and calcium appear to protect against the development of inflammation (58) .…”